Global Paronychia Treatment Market Growth (Status and Outlook) 2023-2029

Global Paronychia Treatment Market Growth (Status and Outlook) 2023-2029

Paronychia is a nail disease that is an often-tender bacterial or fungal infection of the hand or foot where the nail and skin meet at the side or the base of a finger or toenail. The infection can start suddenly (acute paronychia) or gradually (chronic paronychia).

LPI (LP Information)' newest research report, the “Paronychia Treatment Industry Forecast” looks at past sales and reviews total world Paronychia Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Paronychia Treatment sales for 2023 through 2029. With Paronychia Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paronychia Treatment industry.

This Insight Report provides a comprehensive analysis of the global Paronychia Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paronychia Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paronychia Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paronychia Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paronychia Treatment.

The global Paronychia Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

When no pus is present, warm soaks for acute paronychia is reasonable, even though there is a lack of evidence to support its use. Antibiotics such as clindamycin or cephalexin are also often used, the first being more effective in areas where MRSA is common. If there are signs of an abscess (the presence of pus) drainage is recommended. Chronic paronychia is treated by avoiding whatever is causing it, a topical antifungal, and a topical steroid. In those who do not improve following these measures oral antifungals and steroids may be used or the nail fold may be removed surgically.

This report presents a comprehensive overview, market shares, and growth opportunities of Paronychia Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Mupirocin Ointment
Fusidic Acid Ointment
Gentamicin Ointment
Dicloxacillin

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GlaxoSmithKline
Glenmark Generics
Teva Pharmaceutical Industries
Eli Lilly
Jonakayem Pharma Formulation
Fougera Pharmaceuticals
Taro Pharmaceutical Industries

Please note: The report will take approximately 2 business days to prepare and deliver.